Delirium: Where do we stand?

Current Psychiatry Reports

Volumn 10, Issue 3, 2008, Pages 240-248

  Pae, Chi Un ^a,b   Marks, David M ^c   Han, Changsu ^c   Patkar, Ashwin A ^c   Masand, Prakash ^c  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DROPERIDOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; PEROSPIRONE; PLACEBO; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONSCIOUSNESS LEVEL; COST EFFECTIVENESS ANALYSIS; DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SURVEILLANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EXTRAPYRAMIDAL SYMPTOM; HEALTH EDUCATION; HEART DISEASE; HUMAN; HYPOTENSION; LENGTH OF STAY; LOW DRUG DOSE; MINI MENTAL STATE EXAMINATION; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; QT PROLONGATION; REVIEW; RISK FACTOR; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GAMMA-AMINOBUTYRIC ACID; HUMANS; RISK FACTORS;

EID: 49249093682     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-008-0040-3     Document Type: Review

References (80)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
2. Ely EW, Shintani A, Truman B, et al.: Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004, 291:1753-1762.
3. Pandharipande P, Jackson J, Ely EW: Delirium: acute cognitive dysfunction in the critically ill. Curr Opin Crit Care 2005, 11:360-368.
4. Franco K, Litaker D, Locala J, Bronson D: The cost of delirium in the surgical patient. Psychosomatics 2001, 42:68-73.
5. Iseli RK, Brand C, Telford M, LoGiudice D: Delirium in elderly general medical inpatients: a prospective study. Intern Med J 2007, 37:806-811.
6. Taber N, Howard R: Prevention, diagnosis and treatment of delirium: staff educational approaches. Expert Rev Neurother 2006, 6:741-751.
7. Pun BT, Ely EW: The importance of diagnosing and managing ICU delirium. Chest 2007, 132:624-636.
8. Ely EW, Stephens RK, Jackson JC, et al.: Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004, 32:106-112.
9. Gleason OC: Delirium. Am Fam Physician 2003, 67:1027-1034.
10. Van Rompaey B, Schuurmans MJ, Shortridge-Baggett LM, et al.: Risk factors for intensive care delirium: a systematic review. Intensive Crit Care Nurs 2008, 24:98-107.
11. Inouye SK, Zhang Y, Jones RN, et al.: Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med 2007, 167:1406-1413.
12. Kalisvaart KJ, Vreeswijk R, de Jonghe JF, et al.: Risk factors and prediction of postoperative delirium in elderly hip-surgery patients: implementation and validation of a medical risk factor model. J Am Geriatr Soc 2006, 54:817-822.
13. Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996, 275:852-857.
14. Leslie DL, Zhang Y, Bogardus ST, et al.: Consequences of preventing delirium in hospitalized older adults on nursing home costs. J Am Geriatr Soc 2005, 53:405-409.
15. Rabinowitz T, Murphy K, Nagle K, et al.: Delirium: pathophysiology, recognition, prevention and treatment. Expert Rev Neurother 2003, 3:343-355.
16. Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000, 5:132-148.
17. Trzepacz PT: Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord 1999, 10:330-334.
18. Kales HC, Kamholz BA, Visnic SG, Blow FC: Recorded delirium in a national sample of elderly inpatients: potential implications for recognition. J Geriatr Psychiatry Neurol 2003, 16:32-38.
19. Edlund A, Lundstrom M, Karlsson S, et al.: Delirium in older patients admitted to general internal medicine. J Geriatr Psychiatry Neurol 2006, 19:83-90.
20. Rigney TS: Delirium in the hospitalized elder and recommendations for practice. Geriatr Nurs 2006, 27:151-157.
21. Thomas C, Hestermann U, Walther S, et al.: Prolonged activation EEG differentiates dementia with and without delirium in frail elderly. J Neurol Neurosurg Psychiatry 2008, 79:119-125.
22. McCusker J, Cole M, Dendukuri N, et al.: The course of delirium in older medical inpatients: a prospective study. J Gen Intern Med 2003, 18:696-704.
23. Manos PJ, Wu R: The duration of delirium in medical and postoperative patients referred for psychiatric consultation. Ann Clin Psychiatry 1997, 9:219-226.
24. McCusker J, Cole M, Dendukuri N, et al.: Delirium in older medical inpatients and subsequent cognitive and functional status: a prospective study. CMAJ 2001, 165:575-583.
25. McAvay GJ, Van Ness PH, Bogardus ST Jr, et al.: Older adults discharged from the hospital with delirium: 1-year outcomes. J Am Geriatr Soc 2006, 54:1245-1250.
26. Leslie DL, Zhang Y, Holford TR, et al.: Premature death associated with delirium at 1-year follow-up. Arch Intern Med 2005, 165:1657-1662.
27. Cole MG, McCusker J, Bellavance F, et al.: Systematic detection and multidisciplinary care of delirium in older medical inpatients: a randomized trial. CMAJ 2002, 167:753-759.
28. Young LJ, George J: Do guidelines improve the process and outcomes of care in delirium? Age Ageing 2003, 32:525-528.
29. Inouye SK, Bogardus ST Jr, Charpentier PA, et al.: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999, 340:669-676.
30. Tabet N, Hudson S, Sweeney V, et al.: An educational intervention can prevent delirium on acute medical wards. Age Ageing 2005, 34:152-156.
31. Rockwood K, Cosway S, Stolee P, et al.: Increasing the recognition of delirium in elderly patients. J Am Geriatr Soc 1994, 42:252-256.
32. Lundstrom M, Edlund A, Karlsson S, et al.: A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc 2005, 53:622-628.
33. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
34. Sunderland T, Hill JL, Mellow AM, et al.: Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc 1989, 37:725-729.
35. Inouye SK, van Dyck CH, Alessi CA, et al.: Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990, 113:941-948.
36. Trzepacz PT, Baker RW, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 1988, 23:89-97.
37. Trzepacz PT, Mittal D, Torres R, et al.: Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001, 13:229-242.
38. Pfeiffer E: A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975, 23:433-441.
39. Schuurmans MJ, Shortridge-Baggett LM, Duursma SA: The Delirium Observation Screening Scale: a screening instrument for delirium. Res Theory Nurs Pract 2003, 17:31-50.
40. Breitbart W, Rosenfeld B, Roth A, et al.: The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997, 13:129-137.
41. Jacobs JW, Bernhard MR, Delgado A, Strain JJ: Screening for organic mental syndromes in the medically ill. Ann Intern Med 1977, 86:40-46.
42. Neelon VJ, Champagne MT, Carlson JR, Funk SG: The NEECHAM Confusion Scale: construction, validation, and clinical testing. Nurs Res 1996, 45:324-330.
43. Ely EW, Inouye SK, Bernard GR, et al.: Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001, 286:2703-2710.
44. Hart RP, Levenson JL, Sessler CN, et al.: Validation of a cognitive test for delirium in medical ICU patients. Psychosomatics 1996, 37:533-546.
45. Hart RP, Best AM, Sessler CN, Levenson JL: Abbreviated cognitive test for delirium. J Psychosom Res 1997, 43:417-423.
46. Bergeron N, Dubois MJ, Dumont M, et al.: Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001, 27:859-864.
47. Devlin JW, Fong JJ, Fraser GL, Riker RR: Delirium assessment in the critically ill. Intensive Care Med 2007, 33:929-940.
48. Schuurmans MJ, Deschamps PI, Markham SW, et al.: The measurement of delirium: review of scales. Res Theory Nurs Pract 2003, 17:207-224.
49. Stagno D, Gibson C, Breitbart W: The delirium subtypes: a review of prevalence, phenomenology, pathophysiology, and treatment response. Palliat Support Care 2004, 2:171-179.
50. Marcantonio E, Ta T, Duthie E, Resnick NM: Delirium severity and psychomotor types: their relationship with outcomes after hip fracture repair. J Am Geriatr Soc 2002, 50:850-857.
51. Peterson JF, Pun BT, Dittus RS, et al.: Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006, 54:479-484.
52. Mittal D, Majithia D, Kennedy R, Rhudy J: Differences in characteristics and outcome of delirium as based on referral patterns. Psychosomatics 2006, 47:367-375.
53. Britton A, Russell R: Multidisciplinary team interventions for delirium in patients with chronic cognitive impairment. Cochrane Database Syst Rev 2004, 2:CD000395.
54. Lonergan E, Britton AM, Luxenberg J, Wyller T: Antipsychotics for delirium. Cochrane Database Syst Rev 2007, 2: CD005594.
55. Carnes M, Howell T, Rosenberg M, et al.: Physicians vary in approaches to the clinical management of delirium. J Am Geriatr Soc 2003, 51:234-239.
56. Practice guideline for the treatment of patients with delirium. American Psychiatric Association. Am J Psychiatry 1999, 156(5 Suppl):1-20.
57. Leentjens AF, Diefenbacher A: A survey of delirium guidelines in Europe. J Psychosom Res 2006, 61:123-128.
58. Trzepacz P, Meagher D: Delirium. In: Textbook of Psychosomatic Medicine. Arlington, VA: American Psychiatric Publishing; 2005.
59. FDA Public Health Advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. US Food and Drug Administration website. http://www.fda.gov/cder/drug/advisory/antipsychotics.htm. Updated April 11, 2005. Accessed February 22, 2008.
60. Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002, 43:175-182.
61. Kim KS, Pae CU, Chae JH, et al.: An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci 2001, 55:515-519.
62. Horikawa N, Yamazaki T, Miyamoto K, et al.: Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 2003, 25:289-292.
63. Mittal D, Jimerson NA, Neely EP, et al.: Risperidone in the treatment of delirium: results from a prospective open-label trial. J Clin Psychiatry 2004, 65:662-667.
64. Parellada E, Baeza I, de Pablo J, Martinez G: Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004, 65:348-353.
65. Schwartz TL, Masand PS: Treatment of delirium with quetiapine. Prim Care Companion J Clin Psychiatry 2000, 2:10-12.
66. Kim KY, Bader GM, Kotlyar V, Gropper D: Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003, 16:29-31.
67. Sasaki Y, Matsuyama T, Inoue S, et al.: A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003, 64:1316-1321.
68. Pae CU, Lee SJ, Lee CU, et al.: A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol 2004, 19:125-127.
69. Alao AO, Moskowitz L: Aripiprazole and delirium. Ann Clin Psychiatry 2006, 18:267-269.
70. Straker DA, Shapiro PA, Muskin PR: Aripiprazole in the treatment of delirium. Psychosomatics 2006, 47:385-391.
71. Leso L, Schwartz TL: Ziprasidone treatment of delirium. Psychosomatics 2002, 43:61-62.
72. Young CC, Lujan E: Intravenous ziprasidone for treatment of delirium in the intensive care unit. Anesthesiology 2004, 101:794-795.
73. Lee KU, Won WY, Lee HK, et al.: Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol 2005, 20:311-314.
74. Takeuchi T, Furuta K, Hirasawa T, et al.: Perospirone in the treatment of patients with delirium. Psychiatry Clin Neurosci 2007, 61:67-70.
75. Akechi T, Uchitomi Y, Okamura H, et al.: Usage of haloperidol for delirium in cancer patients. Support Care Cancer 1996, 4:390-392.
76. Han CS, Kim YK: A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004, 45:297-301.
77. Kim JY, Jung IK, Han C, et al.: Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 2005, 59:183-188.
78. Skrobik YK, Bergeron N, Dumont M, Gottfried SB: Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004, 30:444-449.
79. Hu X, Deng W, Yang H: A prospective random control study comparison of olanzapine and haloperidol in senile delirium. Chongging Med J 2004, 8:1234-1237.
80. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al.: Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005, 53:1658-1666.